Search

Satoshi Tanida, Keiji Ozeki, Tsutomu Mizoshita, Hironobu Tsukamoto, Takahito Katano, Hiromi Kataoka, Takeshi Kamiya, Takashi Joh Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Aichi Prefecture, Japan Abstract: The goals of treatment for active Crohn's disease (CD) are to achieve clinical remission and improve quality of life. Conventional therapeutics for moderate-to-severe CD include 5-aminosalicylic acid, corticosteroids, purine analogs, azathioprine, and 6-mercaptopurine. Patients who fail to respond to conventional therapy are treated with tumor necrosis factor (TNF)-α inhibitors such as infliximab and adalimumab, but their efficacy is limited due to primary nonresponse or loss of response. It is suggested that this requires switch to another TNF-α inhibitor, a combination therapy with TNF-α blockade plus azathioprine, or granulocyte and monocyte adsorptive apheresis, and that other therapeutic options having different mechanisms of action, such as blockade of inflammatory cytokines or adhesion molecules, are needed. Natalizumab and vedolizumab are neutralizing antibodies directed against integrin a4 and a4ß7, respectively. Ustekinumab is a neutralizing antibody directed against the receptors for interleukin-12 and interleukin-23. Here, we provide an overview of therapeutic treatments that are effective and currently available for CD patients, as well as some that likely will be available in the near future. We also discuss the advantages of managing patients with refractory CD using a combination of TNF-α inhibitors plus azathioprine or intensive monocyte adsorptive apheresis. Keywords: adalimumab, granulocyte and monocyte adsorptive apheresis, combination therapy, complete remission

Malkanthi Evans,1 John A Rumberger,2 Isao Azumano,3 Joseph J Napolitano,4 Danielle Citrolo,5 Toshikazu Kamiya5 1KGK Synergize Inc, London, ON, Canada; 2The Princeton Longevity Center, Princeton, NJ, USA; 3Daiichi Fine Chemical Co, Ltd, Toyama, Japan; 4Independent Consultant, Allentown, PA, USA; 5Kyowa Hakko USA, New York, NY, USA Abstract: High serum concentration of low-density lipoprotein cholesterol (LDL-C) is a major risk factor for coronary heart disease. The efficacy of pantethine treatment on cardiovascular risk markers was investigated in a randomized, triple-blinded, placebo-controlled study, in a low to moderate cardiovascular disease (CVD) risk North American population eligible for statin therapy, using the National Cholesterol Education Program (NCEP) guidelines. A total of 32 subjects were randomized to pantethine (600 mg/day from weeks 1 to 8 and 900 mg/day from weeks 9 to16) or placebo. Compared with placebo, the participants on pantethine showed a significant decrease in total cholesterol at 16 weeks (P=0.040) and LDL-C at 8 and 16 weeks (P=0.020 and P=0.006, respectively), and decreasing trends in non-high-density lipoprotein cholesterol at week 8 and week 12 (P=0.102 and P=0.145, respectively) that reached significance by week 16 (P=0.042). An 11% decrease in LDL-C from baseline was seen in participants on pantethine, at weeks 4, 8, 12, and 16, while participants on placebo showed a 3% increase at week 16. This decrease was significant between groups at weeks 8 (P=0.027) and 16 (P=0.010). The homocysteine levels for both groups did not change significantly from baseline to week 16. Coenzyme Q10 significantly increased from baseline to week 4 and remained elevated until week 16, in both the pantethine and placebo groups. After 16 weeks, the participants on placebo did not show significant improvement in any CVD risk end points. This study confirms that pantethine lowers cardiovascular risk markers in low to moderate CVD risk participants eligible for statins according to NCEP guidelines. Keywords: nutritional and metabolic diseases, hypercholesterolemia, pantethine, cardiovascular diseases, dietary supplements, controlled clinical trial

The control of laser emission angles in laser devices is essential for many optoelectronic and photonic applications such as optical sensing and displays. In this context, we studied the light diffraction pattern of laser beams in a one-dimensional sampled distributed feedback resonator having organic gain media. The gratings consist of the repetition of supercells having a mixed-order sampled grating in which 1st-order gratings surround a 2nd-order grating. The experimental results showed that the diffraction angles of the laser beams are quite diverse depending on the supercell structures. We demonstrate that the interval of the diffraction angle (θ) of the laser beams is inversely proportional to the length of the supercell experimentally and theoretically. By tuning the length of supercells as well as the length of 1st-order and 2nd-order regions, the interval θ was tuned from 0.1° to 43° with the different arc emission patterns. With the reduction of θ, i.e., the longer 1st-order region, a significant decrease in the laser threshold was obtained, resulting in the lowest lasing threshold of 2.5 ± 0.1 μJ/cm2 with ∼3.5 ns of a long pulse width excitation source. [ABSTRACT FROM AUTHOR]

The distribution of organisms at small spatial scales and their use of microhabitats are important determinants of species-level interactions. In many ubiquitous rocky shore invertebrates, use of intertidal microhabitats has previously been studied with relation to thermal and desiccation stress, ontogenetic changes and predation. Here, the effects of parasitism on the microhabitat use and movement of two New Zealand littorinid hosts, Austrolittorina antipodum and A. cincta, were investigated by examining the effect of infection by a philophthalmid trematode parasite. Alterations in microhabitat use and movement of infected versus uninfected individuals were found during both field mark-recapture and laboratory experiments, carried out from August 2012 to March 2013 in Otago Harbour, New Zealand (45.83°S, 170.64°E). Specifically, a trend towards increased use of rock surface habitats and a reduction in the distance moved by infected snails was observed. In addition, decreased downward movement was observed for some infected individuals. This alteration in individual distribution is likely to increase the availability of infected individuals to predators, hence aiding the successful transmission of the trematode parasite. These results highlight the importance of including parasitism as a biotic factor in studies of gastropod movement and spatial distribution., Introduction The intertidal zone has provided an ideal study system for investigating the interactions among species within ecological communities, or between species and the abiotic environment. For example, studies of [...]